arformoterol
CHEBI:CHEBI_408174
Definition
An N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide in which both of the stereocentres have R configuration. The active enantiomer of formoterol, it is administered by inhalation (generally as the tartrate salt) as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).
Chemical Information
- Molecular Formula
- C19H24N2O4
- Molecular Mass
- 344.40490
- Charge
- 0
- SMILES
- [H]C(=O)Nc1cc(ccc1O)[C@@H](O)CN[C@H](C)Cc1ccc(OC)cc1
- InChI
- InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1
- InChIKey
- BPZSYCZIITTYBL-YJYMSZOUSA-N
Alternative Names
- (-)-formoterol
- (R,R)-formoterol
- arformoterol
- N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide
Drug Classification
-
t213572
-
t213671
-
t214099
-
t214348
-
t214383
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:408174
- DRON_00010000
- 304962
- oboInOwl#hasDbXref
- PMID:20406080
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- core#notation
- CHEBI:408174
- rxcui
- 695935
- pharm_class
- beta2-Adrenergic Agonist [EPC]
- package_marketing_start_date
- 02-JUL-12
- manufacturer_name
- Lifestar Pharma LLC
- active_ingredient_strength
- 15 ug/2mL
- active_ingredient_name
- ARFORMOTEROL TARTRATE
- unii
- 5P8VJ2I235
- spl_set_id
- 6a498c49-042f-481f-bc5c-a2fc00dc5668
- upc
- 0370748175019
- package_description
- 30 POUCH in 1 CARTON (27437-055-30) / 1 VIAL, SINGLE-DOSE in 1 POUCH (27437-055-01) / 2 mL in 1 VIAL, SINGLE-DOSE
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- listing_expiration_date
- 20241231
- route
- RESPIRATORY (INHALATION)
- marketing_start_date
- 20220528
- spl_id
- 8f4d31ae-a0b8-426a-92c8-7583ee585abd
- package_ndc
- 72603-208-60
- labeler_name
- Inke SA
- BFO_0000051
- http://purl.obolibrary.org/obo/CHEBI_5147
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect23598
- chebi#is_enantiomer_of
- http://purl.obolibrary.org/obo/CHEBI_63081
- chebi#is_conjugate_acid_of
- http://purl.obolibrary.org/obo/CHEBI_63107
- owl#annotatedSource
- t214483
- owl#someValuesFrom
- t3363383
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 304962
- oboInOwl#hasDbXref
- PMID:20406080
- oboInOwl#id
- CHEBI:408174
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- SOLUTION
- generic_name
- Arformoterol Tartrate Inhalation
- brand_name
- Arformoterol Tartrate Inhalation
- brand_name_base
- Arformoterol Tartrate Inhalation
- product_ndc
- 72603-208
- application_number
- ANDA213762
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_35522
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#is_conjugate_base_of
- http://purl.obolibrary.org/obo/CHEBI_63107